Skip to main content
. 2019 Mar 21;104(8):3345–3354. doi: 10.1210/jc.2018-02536

Table 2.

Associations Between HbA1c and All-Cause Mortality According to the Cutoffs Deriving From the U-Shaped and Reverse J–Shaped Curves

Cutoffs HR (95% CI) for All-Cause Mortality
Participants With Diabetes
Model 1 Model 2 Model 3
Very low (<5.40%; n = 189) 1.84 (1.34, 2.52) 1.80 (1.31, 2.47) 1.66 (1.19, 2.33)
Medium-low (5.40–5.60%; n = 215) 1.02 (0.71, 1.48) 1.04 (0.72, 1.50) 1.07 (0.74, 1.55)
Medium (>5.60 and <7.37%; n = 2323) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Medium-high (7.37–8.43%; n = 550) 1.22 (0.98, 1.52) 1.19 (0.95, 1.48) 1.25 (0.99, 1.58)
Very high (>8.43%; n = 547) 1.49 (1.18, 1.88) 1.44 (1.13, 1.82) 1.40 (1.09, 1.80)
Participants Without Diabetes
Very low (<4.88%; n = 736) 1.74 (1.36, 2.24) 1.69 (1.31, 2.17) 1.60 (1.21, 2.07)
Low (4.88–5.02%; n = 1002) 1.27 (1.02, 1.60) 1.29 (1.03, 1.62) 1.30 (1.02, 1.65)
Medium-low (>5.02 and <5.38%; n = 2,992) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Medium-high 1 (5.38–5.70%; n = 3628) 1.13 (0.97, 1.32) 1.16 (1.00, 1.36) 1.13 (0.96, 1.33)
Medium-high 2 (>5.70%; n = 3687) 1.14 (0.99, 1.32) 1.12 (0.96, 1.30) 1.11 (0.95, 1.30)

Model 1: adjusted for age, sex, and race. Model 2: further adjusted for BMI, education level, smoking, and drinking. Model 3: further adjusted for cognitive function scores, CES-D scores, hypertension, heart disease, stroke, lung disease, psychiatric problems, C-reactive protein, and total cholesterol. Model 3 was considered to be the fully adjusted model. Data in boldface indicate statistical significance at 5% level.